EU Authorised Representative for Medical Devices and IVDs Across Europe
For non-EU manufacturers, bringing medical devices or in vitro diagnostic devices into the European market involves more than product quality, technical documentation and regulatory preparation. Before a device can be placed on the European market, the manufacturer must appoint an EU Authorized Representative based within the European Union and formally recognised as the manufacturer’s authorised representative. This function is critical under the Medical Device Regulation and the In Vitro Diagnostic Medical Device Regulation as regulators require a responsible local entity to manage communication, supply documentation and assist with compliance obligations when needed. An eu-authorized-representative is not simply a name on a label. They serve as the legal presence of a non-EU manufacturer and play a vital role in ensuring market access, regulatory trust and ongoing post-market accountability.
Why an EU Authorized Representative Is Required
European medical device rules are designed to protect patients, healthcare professionals and users by ensuring that every product placed on the market has a clear chain of responsibility. If a manufacturer operates outside the European Union, regulators cannot always interact with them as easily as they would with a locally established company. This is exactly where the EU Authorized Representative becomes essential. The representative offers a formal European presence and acts as the official contact for Competent Authorities, Notified Bodies and other regulatory parties.
Without appointing an authorised representative, a non-EU manufacturer cannot legally place medical devices or IVDs on the European market. This requirement applies across a broad spectrum of products, from low-risk devices to advanced diagnostic technologies. This obligation applies before market entry, meaning the representative must be selected early in the compliance journey rather than as a last administrative step. For companies preparing for European distribution, selecting the right EU Authorized Representative for Medical Devices and IVDs can significantly influence registration readiness, document management and long-term regulatory stability.
The Written Mandate Between Manufacturer and Representative
The connection between the manufacturer and the EU Authorized Representative must be formalised through a written mandate. This mandate defines the tasks the representative is authorised to perform and confirms the obligations both parties must follow. It is a key compliance document because it sets out the scope of representation, responsibilities, communication duties and actions required if compliance concerns arise.
An unclear or weakly drafted mandate can cause uncertainty at critical moments, particularly during authority requests, inspections, complaint handling or corrective actions. A robust mandate should clearly explain document availability, regulatory communication procedures, incident reporting processes and the steps taken if the manufacturer fails to meet obligations. Therefore, the mandate must be carefully drafted and reviewed before registration or market entry begins.
Label and Packaging Requirements
The name and address of the EU Authorized Representative must appear on the device label, packaging or related product information as required by the applicable regulation. This allows authorities, distributors, healthcare professionals and users to identify the local representative linked to the device. It also reinforces the representative’s role as the official European presence for a manufacturer located outside the European Union.
Labelling accuracy matters because incorrect or missing representative information can create compliance concerns and may delay market access. Manufacturers should ensure that their artwork, instructions, declarations and registration information are aligned before products are released. If the representative changes, labelling and registration details may also need to be updated in a controlled and timely manner.
Documentation Review and Availability
One of the important duties of an EU Authorized Representative for Medical Devices and IVDs is to verify that key compliance documents are available and properly prepared. This includes checking that the EU Declaration of Conformity exists, that technical documentation has been compiled and that the manufacturer has followed an appropriate conformity assessment route for the device type and risk class.
The representative may also be required to retain or access copies of technical files, declarations and Notified Body certificates. These records must remain accessible for inspection by Competent Authorities for the specified retention period after the last device is marketed. This places document control at the core of the manufacturer–representative relationship. Manufacturers should maintain updated records and ensure that the representative can respond quickly if regulators request information.
Communication With Competent Authorities and Notified Bodies
The EU Authorized Representative serves as the formal communication link between the non-EU manufacturer and European regulatory authorities. If a Competent Authority requests information, samples, technical documentation or clarification, the representative is expected to support the response process. The representative may also liaise with Notified Bodies when necessary, particularly regarding certification, conformity assessments or corrective measures.
This communication function goes beyond simply passing messages. A dependable representative should understand regulatory requirements, maintain accurate records and ensure responses are delivered within required timelines. Late or incomplete replies can lead to serious consequences, including market limitations or additional regulatory scrutiny. Therefore, manufacturers should partner with a representative who has strong regulatory expertise and well-defined internal systems.
Post-Market Surveillance and Incident Support
Compliance for medical devices does not stop once the product reaches the market. Once a device is in use, manufacturers must continue monitoring performance, complaints, incidents and safety signals. The EU Authorized Representative has a role in supporting this post-market responsibility by passing complaints and incident information to the manufacturer without delay.
This is especially important when information comes from clinicians, patients, users, distributors or authorities. Timely reporting allows the manufacturer to determine whether investigation, reporting, field safety actions or corrective measures are required. A strong representative understands that post-market surveillance is not just paperwork. It plays a key role in patient safety, product enhancement and continued regulatory confidence.
Registration Responsibilities and EUDAMED
Within European regulatory frameworks, manufacturer and representative details must be registered as necessary. The EU Authorized Representative may support the registration of both the manufacturer and representative information in EUDAMED. Accurate registration enables authorities to identify responsible entities, review device data and maintain market supervision.
Manufacturers should gather complete company information, device details, certificates and declarations before starting registration. Any inconsistency between labels, declarations, technical files and registration records can create delays or compliance questions. The representative’s role helps ensure all required information is aligned and accessible when required.
When the Representative Must Take Action
An EU Authorized Representative also carries responsibilities if the manufacturer does not fulfil regulatory requirements. If serious non-compliance occurs and the manufacturer does not correct the issue, the representative may need to end the mandate and inform relevant authorities and the Notified Body where applicable. This responsibility shows why the role is more than administrative.
The representative has legal accountability and cannot ignore major compliance failures. Manufacturers should therefore view the representative as a regulatory partner rather than a passive provider. Clear communication, regular document updates and defined responsibilities help avoid misunderstandings and minimise risk throughout the product lifecycle.
Choosing the Right EU Authorized Representative
Choosing an EU Authorized Representative requires careful consideration. Manufacturers should evaluate regulatory expertise, experience in medical devices and IVDs, document management capabilities, clear response processes and strong knowledge of European eu-authorized-representative regulations. The representative should be able to support communication with authorities, maintain records and guide the manufacturer on practical compliance expectations.
Cost alone should not determine the choice. An ineffective representative may lead to delays, communication gaps and increased risk, whereas a strong representative can support confidence during market entry and beyond. The right choice gives non-EU manufacturers a dependable European presence and supports smoother regulatory management.
Conclusion
An EU Authorized Representative is a mandatory requirement for non-EU manufacturers aiming to introduce medical devices or IVDs into the European market. The role includes legal representation, documentation availability, authority communication, complaint handling, registration support and action in cases of serious non-compliance. Under the Medical Device Regulation and the In Vitro Diagnostic Medical Device Regulation, appointing an authorised representative is mandatory and must be done before market entry. By selecting a capable EU Authorized Representative for Medical Devices and IVDs, manufacturers can enhance compliance, protect patient safety and establish a solid foundation for long-term European market access.